For coagulation tests and as a rinsing solution for the sample needles of the Sy
For coagulation tests and as a rinsing solution for the sample needles of the Sysmex® CA Systems
N/T Protein Control SL/M is a medium level, multi-analyte control for use as acc
N/T Protein Control SL/M is a medium level, multi-analyte control for use as accuracy and precision control in the determination of human serum proteins by immunonephelometry with the BN Systems
N/T Protein Control SL/H is a high level, multi-analyte control for use as accur
N/T Protein Control SL/H is a high level, multi-analyte control for use as accuracy and precision control in the determination of human serum proteins by immunonephelometry with the BN Systems
For the determination of the activity of coagulation factor X in human plasma by
For the determination of the activity of coagulation factor X in human plasma by coagulometric methods
For the determination of the activity of coagulation factor XI in human plasma b
For the determination of the activity of coagulation factor XI in human plasma by coagulometric methods
Quantitative determination of soluble transferrin receptor (sTfR) in human serum
Quantitative determination of soluble transferrin receptor (sTfR) in human serum and heparinized plasma on BN Systems
LA 1 Screening Reagent. Simplified DRVV reagent to screen for the presence of Lu
LA 1 Screening Reagent. Simplified DRVV reagent to screen for the presence of Lupus Anticoagulants
For use as a low level assayed control for the quantitative measurement of low m
For use as a low level assayed control for the quantitative measurement of low molecular weight heparin with Berichrom Heparin
For calibration of the Berichrom Heparin assay for measurement of low molecular
For calibration of the Berichrom Heparin assay for measurement of low molecular weight heparin
JPA
SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES
For use as a high level assayed control for the quantitative measurement of unfr
For use as a high level assayed control for the quantitative measurement of unfractionated heparin with Berichrom Heparin
Quantitative determination of homocysteine in human serum and plasma on BN II an
Quantitative determination of homocysteine in human serum and plasma on BN II and BN ProSpec® Systems
CYSC CON L is an assayed intralaboratory quality control for assessment of preci
CYSC CON L is an assayed intralaboratory quality control for assessment of precision and analytical bias in the determination of the CYSC method on the Dimension Vista® System
PROT1 CON M is an assayed, mid-level, intralaboratory, multi-analyte quality con
PROT1 CON M is an assayed, mid-level, intralaboratory, multi-analyte quality control for the assessment of precision and analytical bias on the Dimension Vista® System
For the quantitative measurement of immunoglobulin E in human serum and plasma (
For the quantitative measurement of immunoglobulin E in human serum and plasma (heparin or EDTA) on the Dimension Vista® System
DGC
IGE, ANTIGEN, ANTISERUM, CONTROL
DImension Vista® Immunoglobulin E Flex® reagent cartridge
For the quantitative measurement of C-reactive protein in human serum and plasma
For the quantitative measurement of C-reactive protein in human serum and plasma on the Dimension Vista® System
NQD
CARDIAC C-REACTIVE PROTEIN, ANTIGEN, ANTISERUM, AND CONTROL
For the quantitative measurement of total homocysteine in human serum and plasma
For the quantitative measurement of total homocysteine in human serum and plasma on the Dimension Vista® System
The DIMERTEST® Latex Assay is intended for the rapid qualitative or semiquantita
The DIMERTEST® Latex Assay is intended for the rapid qualitative or semiquantitative evaluation of circulating derivatives of cross-linked fibrin degradation products (XL-FDP) in human plasma
DAP
FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL
For differential staining in hematology that gives results similar to a Wright-G
For differential staining in hematology that gives results similar to a Wright-Giemsa stain
Assayed accuracy and precision controls in the determination of free light chain
Assayed accuracy and precision controls in the determination of free light chains (FLC) type kappa and type lambda on BN Systems.
Assayed accuracy and precision controls in the determination of free light chain
Assayed accuracy and precision controls in the determination of free light chains (FLC) type kappa and type lambda on BN Systems.
The BN ProSpec® is a system for the quantitative determination of proteins in se
The BN ProSpec® is a system for the quantitative determination of proteins in serum, plasma, urine and CSF
Quantitative determination of carbohydrate-deficient transferrin (CDT) in human
Quantitative determination of carbohydrate-deficient transferrin (CDT) in human serum on BN II and BN ProSpec® Systems
Qualitative detection or semi-quantitative determination of C-reactive protein (
Qualitative detection or semi-quantitative determination of C-reactive protein (CRP) in human serum
Qualitative detection or semi-quantitative determination of C-reactive protein (
Qualitative detection or semi-quantitative determination of C-reactive protein (CRP) in human serum
Control plasma for assays aimed to determine the functional phenotype for activa
Control plasma for assays aimed to determine the functional phenotype for activated protein C resistance caused by the Factor V Leiden mutation (FV:Q506).
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively.
ROTROL P is a quality control material for monitoring accuracy and precision of
ROTROL P is a quality control material for monitoring accuracy and precision of tests carried out on the ROTEM® delta Thromboelastometry System. For in vitro diagnostic use only.
ROTROL N is a quality control material for monitoring accuracy and precision of
ROTROL N is a quality control material for monitoring accuracy and precision of tests carried out on the ROTEM® delta Thromboelastometry System. For in vitro diagnostic use only.
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environ-ment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve – clot firmness over time) and several defined numerical parameters describing the curve quantitatively.The star-tem® reagent is intended for use as recalcification reagent in the NATEM and INTEM assay on the ROTEM® delta. The corresponding assays are described in the NATEM assay application sheet and in the Instructions for Use of the in-tem® reagent (REF 503-02-US), resp.
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environ-ment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively.The hep-tem® assay is a semi-quantitative in vitro diagnostic assay used to inactivate heparin in patients receiving unfractionated heparin on the ROTEM® delta. To monitor the coagulation process citrated whole blood specimens are used. Clotting characteristics are described by the functional parameters Clotting Time (CT), Speed of Clot Formation (CFT and alpha angle), Clot Firmness (A20/MCF) and Clot Lysis (LOT, ML, LI(x)).
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively.The in-tem® assay is a semi-quantitative in vitro diagnostic assay used to monitor the coagulation process via the intrinsic pathway in citrated whole blood specimens on the ROTEM® delta. Clotting characteristics are described by the functional parameters Clotting Time (CT), Speed of Clot Formation (CFT and alpha angle), Clot Firmness (A20/MCF) and Clot Lysis (LOT, ML, LI(x)).
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively.